IE
OCAT

Israel Englander’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Israel Englander’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,600
Closed -$106K – 3976
2015
Q4 		$106K Buy
+12,600
New +$84.3K ﹤0.01% 3235
2015
Q2 		– Sell
-51,840
Closed -$319K – 4168
2015
Q1 		$319K Buy
+51,840
New +$332K ﹤0.01% 3000

Israel Englander's OCAT Position: Q1 2016 in Review

Israel Englander sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 12,600 shares — an estimated $106K sold.

Israel Englander first reported a position in OCAT in Q1 2015 and held it in 2 quarters. The position peaked at $319K in Q1 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Israel Englander reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Israel Englander sold 12,600 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $106K.
  • Israel Englander first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 2 quarters.
  • Israel Englander's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $319K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Millennium Management's 13F filing for Q1 2016, filed 16 May 2016.